The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

Despite new treatment modalities, the clinical outcome in a substantial number of patients with multiple myeloma (MM) has yet to be improved. Antibody-based targeted therapies for myeloma patients could make use of the HM1.24 antigen (CD317), a surface molecule overexpressed on malignant plasma cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Staudinger, M, Glorius, P, Burger, R, Kellner, C, Klausz, K, Günther, A, Repp, R, Klapper, W, Gramatzki, M, Peipp, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080209/
https://www.ncbi.nlm.nih.gov/pubmed/24927408
http://dx.doi.org/10.1038/bcj.2014.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080209/
https://www.ncbi.nlm.nih.gov/pubmed/24927408
http://dx.doi.org/10.1038/bcj.2014.38

Ejemplares similares